Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort

Breast cancer represents a heterogeneous condition in which the interaction between host immune response and primary oncogenic events can impact disease progression. Ratios of systemic blood-based immunocytes have emerged as clinically-relevant prognostic biomarkers in cancer patients. The NLR (neut...

Full description

Bibliographic Details
Main Authors: Amirhossein Jalali, David Miresse, Matthew R. Fahey, Niamh Ni Mhaonaigh, Andrew McGuire, Emer Bourke, Michael J. Kerin, James A. L. Brown
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Oncology
Subjects:
breast
monocytes
lymphocytes
neutrophils
basophils
eosinophils
Online Access:https://www.mdpi.com/1718-7729/29/10/591

Internet

https://www.mdpi.com/1718-7729/29/10/591

Similar Items